Intra-hematoma Rosiglitazone infusion therapy attenuates blood-brain barrier disruption after intracerebral hemorrhage in rabbits

Objective: To observe the effect of intra-hematoma Rosiglitazone (RSG) infusion therapy in treating intracerebral hemorrhage (ICH). Specifically, to explore the effects of RSG on tight junction associated proteins Occludin and ZO-1 expression within perihematomal brain tissues as well as the blood–b...

Full description

Bibliographic Details
Main Authors: Siying Ren, Likun Wang, Guofeng Wu, Lei Huang, Zhouping Tang
Format: Article
Language:English
Published: KeAi Communications Co., Ltd. 2023-06-01
Series:Brain Hemorrhages
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2589238X23000013